Jubilant Pharmova Limited (BOM:530019)
India · Delayed Price · Currency is INR 944.40
+6.25 (0.67%)
At close: Oct 16, 2026
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 149.58 billion as of October 16, 2026. It is the 7,801st most valuable company in the world and the 464th biggest in India. Its market cap has decreased by 12.16% in one year.
Market Cap
149.58B
Enterprise Value
173.08B
Revenue
86.08B
Global Rank
Country Rank
#464 India
PE Ratio
42.60
ChartMarket Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 149.58B, an increase of 36,676.36%. That is a compound annual growth rate of 25.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 149.58B | -12.13% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 427.41B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 201.45B |
| Caplin Point Laboratories | 175.06B |
| AstraZeneca Pharma India | 148.07B |
| Viyash Scientific | 98.55B |
| Procter & Gamble Health | 85.68B |
| Bliss GVS Pharma | 69.75B |